Combined Treatment with Pravastatin and Gemfibrozil in Patients with Refractory Familial Combined Hyperlipidaemia
Explore this paper's citation graph
Summary
Combined treatment with gemfibrozil and pravastatin is safe and effective, but should be administered only in selected patients with severe combined hyperlipidaemia.
- Type
- article
- Published
- 1994-03-01
- Cited by
- 12
- References
- 44
- OpenAlex
- https://openalex.org/W77961882
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:68198199
Keywords
Pravastatin, Gemfibrozil, Medicine, Internal medicine, Placebo
References
- Treatment of severe, resistant familial combined hyperlipidemia with a bezafibrate-lovastatin combination.
- Acquired hyperlipidemia (secondary dyslipoproteinemias).
- Pravastatin--ocular side effects after a two year follow-up?
- Lipids as a coronary risk factor: analysis of hyperlipidaemias.
- Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.
- Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia.
- Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
- Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism.
- Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study.
- Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man.
- Mechanism of action of gemfibrozil on lipoprotein metabolism.
- Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine.
- HMG-CoA reductase inhibitors for treatment of hypercholesterolemia.
- Drug treatment of hyperlipidemia.
- Comparative effects of pravastatin and lovastatin on nighttime sleep and daytime performance
- Effects of lovastatin and pravastatin on sleep efficiency and sleep stages
- Atherosclerosis and apoproteins B and A-I.
- Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment.
- Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levels
- Pravastatin vs Gemfibrozil in the Treatment of Primary Hypercholesterolaemia
Cited by
- Effect of Atorvastatin versus Simvastatin on Lipid Profile and Plasma Fibrinogen in Patients with Hypercholesterolaemia
- Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia.
- Pilot Study of the Effect of the Simvastatin-Ciprofibrate Combination on Myocardial Infarction Risk Profile in Patients with Refractory Familial Combined Hyperlipidaemia
- Effect of pravastatin in the prevention of coronary heart disease in patients with primary hypercholesterolemia
- Management of atherogenic dyslipidemia of the metabolic syndrome: evolving rationale for combined drug therapy.
- Long-term safety and efficacy of combination gemfibrozil and HMG-CoA reductase inhibitors for the treatment of mixed lipid disorders.
- Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia.
- Role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors ("statins") in familial combined hyperlipidemia.
- Atorvastatin versus Four Statin–Fibrate Combinations in Patients with Familial Combined Hyperlipidaemia
- Statin—Fibrate Combination Therapy
- Dyslipidaemia of Obesity, Metabolic Syndrome and Type 2 Diabetes Mellitus: the Case for Residual Risk Reduction After Statin Treatment
- Composition pharmaceutique comprenant une combinaison de nitrate d'isosorbide et d'acide acetylsalicylique
Related papers
- Pravastatin vs gemfibrozil in the treatment of primary hypercholesterolemia. The Italian Multicenter Pravastatin Study I.
- Pravastatin vs Gemfibrozil in the Treatment of Primary Hypercholesterolaemia
- A comparison of pravastatin and gemfibrozil in the treatment of dyslipoproteinemia in patients with non-insulin-dependent diabetes mellitus.
- Gemfibrozil and its glucuronide inhibit the hepatic uptake of pravastatin mediated by OATP1B1
- Plasma lipoprotein changes after treatment with pravastatin and gemfibrozil in patients with familial hypercholesterolemia.
- Treatment of patients with familial defective apolipoprotein B-100 with pravastatin and gemfibrozil: a two-period cross-over study
- Inhibition of human organic anion transporter 3 mediated pravastatin transport by gemfibrozil and the metabolites in humans
- Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearance
- Long-term Treatment With Pravastatin Alone and in Combination With Gemfibrozil in Familial Type IIB Hyperlipoproteinemia or Combined Hyperlipidemia